{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:00Z","timestamp":1790789940473,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>. Transplant recipients may develop rejection despite having adequate tacrolimus whole blood predose concentrations (C<jats:sub>0<\/jats:sub>). The intra-immune cellular concentration is potentially a better target than C<jats:sub>0<\/jats:sub>. However, little is known regarding intracellular tacrolimus concentration in T-lymphocytes and monocytes. We investigated the tacrolimus concentrations in both cell types and their relation with the expression and activity of FK-binding protein (FKBP)-12 and P-glycoprotein (P-gp).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>. T-lymphocytes and monocytes were isolated from kidney transplant recipients followed by intracellular tacrolimus concentration measurement. FKBP-12 and P-gp were quantified with Western blot, flow cytometry, and the Rhodamine-123 assay. Interleukin-2 and interferon-\u03b3 in T-lymphocytes were measured to quantify the effect of tacrolimus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>. Tacrolimus concentration in T-lymphocytes was lower than in monocytes (15.3 [8.5\u201333.4] versus 131.0 [73.5\u2013225.1] pg\/million cells; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The activity of P-gp (measured by Rhodamine-123 assay) was higher in T-lymphocytes than in monocytes. Flow cytometry demonstrated a higher expression of P-gp (normalized mean fluorescence intensity 1.5 [1.2\u20131.7] versus 1.2 [1.1\u20131.4]; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.012) and a lower expression of FKBP-12 (normalized mean fluorescence intensity 1.3 [1.2\u20131.7] versus 1.5 [1.4\u20132.0]; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.011) in T-lymphocytes than monocytes. Western blot confirmed these observations. The addition of verapamil, a P-gp inhibitor, resulted in a 2-fold higher intra-T-cell tacrolimus concentration. This was accompanied by a significantly fewer cytokine-producing cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>. T-lymphocytes have a higher activity of P-gp and lower concentration of the FKBP-12 compared with monocytes. This explains the relatively lower tacrolimus concentration in T-lymphocytes. The addition of verapamil prevents loss of intracellular tacrolimus during the cell isolation process and is required to ensure adequate intracellular concentration measurement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004287","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T21:00:09Z","timestamp":1662584409000},"page":"382-391","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["P-glycoprotein, FK-binding Protein-12, and the Intracellular Tacrolimus Concentration in T-lymphocytes and Monocytes of Kidney Transplant Recipients"],"prefix":"10.1097","volume":"107","author":[{"given":"Suwasin","family":"Udomkarnjananun","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."},{"name":"Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marith I.","family":"Francke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Dieterich","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van De Velde","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolle H.R.","family":"Litjens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Boer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda C.M.","family":"De Winter","sequence":"additional","affiliation":[{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."},{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/TP.0000000000003350","article-title":"Thirty years of tacrolimus in clinical practice.","volume":"105","author":"Ong","year":"2021","journal-title":"Transplantation"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/TP.0000000000002913","article-title":"Tacrolimus intrapatient variability, time in therapeutic range, and risk of de novo donor-specific antibodies.","volume":"104","author":"Davis","year":"2020","journal-title":"Transplantation"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ajt.12191","article-title":"Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(\u2020).","volume":"13","author":"Bouamar","year":"2013","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"101756","DOI":"10.1016\/j.bpg.2021.101756","article-title":"Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology.","volume":"54\u201355","author":"Udomkarnjananun","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17425255.2017.1395413","article-title":"Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.","volume":"13","author":"Andrews","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report.","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11095-020-02875-z","article-title":"Role of FK506 binding protein on tacrolimus distribution in red blood cells.","volume":"37","author":"Yoshikawa","year":"2020","journal-title":"Pharm Res"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"733285","DOI":"10.3389\/fphar.2021.733285","article-title":"Monitoring intra-cellular tacrolimus concentrations in solid organ transplantation: use of peripheral blood mononuclear cells and graft biopsy tissue.","volume":"12","author":"Sallustio","year":"2021","journal-title":"Front Pharmacol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus.","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"R10-20250604","doi-asserted-by":"crossref","first-page":"i12","DOI":"10.1093\/ndt\/gfg1029","article-title":"Pharmacokinetics of tacrolimus-based combination therapies.","volume":"18","author":"Undre","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FTD.0000000000000780","article-title":"Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel.","volume":"42","author":"Lemaitre","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/eci.09.64","article-title":"Role of T cells in graft rejection and transplantation tolerance.","volume":"6","author":"Issa","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cei.12576","article-title":"Follicular T helper cells and humoral reactivity in kidney transplant patients.","volume":"180","author":"de Graav","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection.","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fimmu.2017.01510","article-title":"T follicular helper cells as a new target for immunosuppressive therapies.","volume":"8","author":"Yan","year":"2017","journal-title":"Front Immunol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation.","volume":"9","author":"Siu","year":"2018","journal-title":"Front Immunol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/FTD.0000000000000982","article-title":"The association between the intracellular tacrolimus concentration in CD3+ T lymphocytes and CD14+ monocytes and acute kidney transplant rejection.","volume":"44","author":"Udomkarnjananun","year":"2022","journal-title":"Ther Drug Monit"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","article-title":"Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.","volume":"80","author":"Chaudhary","year":"1992","journal-title":"Blood"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1182\/blood.V80.11.2729.2729","article-title":"Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.","volume":"80","author":"Drach","year":"1992","journal-title":"Blood"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/TP.0000000000004078","article-title":"A novel high-throughput droplet digital PCR-based INDEL quantification method for the detection of circulating donor-derived cell-free DNA after kidney transplantation.","volume":"106","author":"Verhoeven","year":"2022","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1097\/TXD.0000000000001319","article-title":"Immune subsets from ficoll density gradient separation in kidney transplant recipients.","volume":"8","author":"Udomkarnjananun","year":"2022","journal-title":"Transplant Direct"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e4416","DOI":"10.1002\/bmc.4416","article-title":"Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.","volume":"33","author":"Bahmany","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/bcp.14585","article-title":"Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients.","volume":"87","author":"Francke","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FTD.0b013e31828c1581","article-title":"Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus.","volume":"35","author":"Vafadari","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cyto.a.22995","article-title":"Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages.","volume":"89","author":"Andersen","year":"2016","journal-title":"Cytometry A"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.leu.2400658","article-title":"Monoclonal antibodies specific for P-glycoprotein.","volume":"11","author":"Okochi","year":"1997","journal-title":"Leukemia"},{"key":"R27-20250604","first-page":"1.3.1","article-title":"Standardization, calibration, and control in flow cytometry.","volume":"79","author":"Wang","year":"2017","journal-title":"Curr Protoc Cytom"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting.","volume":"4","author":"Mahmood","year":"2012","journal-title":"N Am J Med Sci"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"rs2","DOI":"10.1126\/scisignal.2005966","article-title":"An analysis of critical factors for quantitative immunoblotting.","volume":"8","author":"Janes","year":"2015","journal-title":"Sci Signal"},{"key":"R30-20250604","first-page":"1.14.1","article-title":"Compensation in flow cytometry.","volume":"22","author":"Roederer","year":"2002","journal-title":"Curr Protoc Cytom"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study.","volume":"25","author":"Capron","year":"2012","journal-title":"Transpl Int"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"e0153491","DOI":"10.1371\/journal.pone.0153491","article-title":"Monitoring the intracellular tacrolimus concentration in kidney transplant recipients with stable graft function.","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/FTD.0000000000000539","article-title":"Longitudinal study of tacrolimus in lymphocytes during the first year after kidney transplantation.","volume":"40","author":"Klaasen","year":"2018","journal-title":"Ther Drug Monit"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.clinthera.2018.10.015","article-title":"Tacrolimus concentrations measured in excreted bile in liver transplant recipients: the STABILE study.","volume":"40","author":"Rayar","year":"2018","journal-title":"Clin Ther"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.12.002","article-title":"Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation.","volume":"101","author":"Francke","year":"2022","journal-title":"Clin Biochem"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3389\/fphar.2018.01425","article-title":"FKBP ligands-where we are and where to go?","volume":"9","author":"Kolos","year":"2018","journal-title":"Front Pharmacol"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/35146","article-title":"Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12.","volume":"391","author":"Shou","year":"1998","journal-title":"Nature"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/jcp.34.10.1083","article-title":"Cell volumes of normal and malignant mononuclear cells.","volume":"34","author":"Chapman","year":"1981","journal-title":"J Clin Pathol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00412-016-0614-5","article-title":"Nuclear morphologies: their diversity and functional relevance.","volume":"126","author":"Skinner","year":"2017","journal-title":"Chromosoma"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/eji.201141717","article-title":"Regulatory macrophages: setting the threshold for therapy.","volume":"41","author":"Fleming","year":"2011","journal-title":"Eur J Immunol"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B cells.","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"Front Immunol"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/TP.0000000000003776","article-title":"Targeting T follicular helper cells to control humoral allogeneic immunity.","volume":"105","author":"Louis","year":"2021","journal-title":"Transplantation"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0000000000003804","article-title":"Macrophages in transplantation: a matter of plasticity, polarization, and diversity.","volume":"106","author":"Panzer","year":"2022","journal-title":"Transplantation"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007691-200108000-00006","article-title":"Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.","volume":"23","author":"Ahmed","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1073\/pnas.1620835114","article-title":"IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.","volume":"114","author":"Whitehouse","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.cca.2011.09.040","article-title":"ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation.","volume":"413","author":"Shuker","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1988.tb06190.x","article-title":"Reversal of drug-resistance in multiple myeloma with verapamil.","volume":"68","author":"Durie","year":"1988","journal-title":"Br J Haematol"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3390\/pharmaceutics8020012","article-title":"Evaluation of P-glycoprotein inhibitory potential using a rhodamine 123 accumulation assay.","volume":"8","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2017.00205","article-title":"Mechanism underlying the reversal of drug resistance in P-glycoprotein-expressing leukemia cells by pinoresinol and the study of a derivative.","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:16:52Z","timestamp":1749061012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004287","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}